Claro Advisors LLC Acquires New Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Claro Advisors LLC bought a new position in Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 655 shares of the medical equipment provider’s stock, valued at approximately $221,000.

Other hedge funds also recently modified their holdings of the company. RB Capital Management LLC raised its holdings in Intuitive Surgical by 4.4% during the first quarter. RB Capital Management LLC now owns 1,735 shares of the medical equipment provider’s stock valued at $523,000 after buying an additional 73 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. raised its holdings in Intuitive Surgical by 0.6% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 946,709 shares of the medical equipment provider’s stock valued at $285,603,000 after buying an additional 5,233 shares in the last quarter. Baird Financial Group Inc. raised its holdings in Intuitive Surgical by 2.3% during the first quarter. Baird Financial Group Inc. now owns 21,089 shares of the medical equipment provider’s stock valued at $6,362,000 after buying an additional 481 shares in the last quarter. Brown Brothers Harriman & Co. raised its holdings in Intuitive Surgical by 576.7% during the first quarter. Brown Brothers Harriman & Co. now owns 406 shares of the medical equipment provider’s stock valued at $122,000 after buying an additional 346 shares in the last quarter. Finally, Covestor Ltd raised its holdings in Intuitive Surgical by 50.4% during the first quarter. Covestor Ltd now owns 418 shares of the medical equipment provider’s stock valued at $126,000 after buying an additional 140 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 3.2 %

ISRG stock opened at $382.36 on Wednesday. Intuitive Surgical, Inc. has a 1-year low of $250.01 and a 1-year high of $403.76. The firm has a market cap of $135.53 billion, a P/E ratio of 76.02, a P/E/G ratio of 6.20 and a beta of 1.36. The business’s 50 day moving average is $386.60 and its 200-day moving average is $335.05.

Intuitive Surgical (NASDAQ:ISRGGet Free Report) last released its quarterly earnings data on Tuesday, January 23rd. The medical equipment provider reported $1.60 earnings per share for the quarter, beating the consensus estimate of $1.48 by $0.12. Intuitive Surgical had a return on equity of 13.11% and a net margin of 25.24%. The company had revenue of $1.93 billion for the quarter, compared to analyst estimates of $1.89 billion. During the same period in the prior year, the company posted $0.91 EPS. The company’s revenue was up 16.6% compared to the same quarter last year. Sell-side analysts forecast that Intuitive Surgical, Inc. will post 4.93 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the company. Wells Fargo & Company raised their target price on Intuitive Surgical from $363.00 to $416.00 and gave the company an “overweight” rating in a report on Friday, January 19th. StockNews.com lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Thursday, February 29th. Barclays lifted their price objective on Intuitive Surgical from $385.00 to $430.00 and gave the stock an “overweight” rating in a research note on Thursday, January 25th. Royal Bank of Canada lifted their price objective on Intuitive Surgical from $400.00 to $432.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 24th. Finally, Truist Financial lifted their price objective on Intuitive Surgical from $390.00 to $435.00 and gave the stock a “buy” rating in a research note on Wednesday, January 24th. Five equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $371.60.

View Our Latest Analysis on ISRG

Insider Transactions at Intuitive Surgical

In other news, EVP Myriam Curet sold 4,318 shares of the business’s stock in a transaction that occurred on Friday, January 26th. The stock was sold at an average price of $370.15, for a total value of $1,598,307.70. Following the transaction, the executive vice president now directly owns 189 shares of the company’s stock, valued at approximately $69,958.35. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Intuitive Surgical news, EVP Myriam Curet sold 4,318 shares of the company’s stock in a transaction on Friday, January 26th. The stock was sold at an average price of $370.15, for a total transaction of $1,598,307.70. Following the transaction, the executive vice president now owns 189 shares of the company’s stock, valued at approximately $69,958.35. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Alan J. Levy sold 2,000 shares of the stock in a transaction on Friday, January 26th. The shares were sold at an average price of $370.20, for a total value of $740,400.00. Following the completion of the transaction, the director now directly owns 25,319 shares in the company, valued at approximately $9,373,093.80. The disclosure for this sale can be found here. Insiders have sold 248,418 shares of company stock valued at $95,927,097 in the last three months. 0.90% of the stock is owned by corporate insiders.

About Intuitive Surgical

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Featured Stories

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.